13D Filing: Aisling Capital III LP and Pernix Therapeutics Holdings Inc. (PTX)

Page 11 of 11

Page 11 of 11 – SEC Filing

CUSIP No. 71426V108
SCHEDULE  13D
Page 11 of 11
  SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date:     February 1, 2018
AISLING CAPITAL III, LP
By:
Aisling Capital Partners III, LP
General Partner
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III, LP
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III LLC
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
/s/ Steve Elms
Steve Elms
/s/ Dennis Purcell
Dennis Purcell
/s/ Andrew Schiff
Andrew Schiff
Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

 

Follow Pernix Therapeutics Holdings Inc. (NASDAQ:PTX)

Page 11 of 11